In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER-3 Drug Master File in Korea (DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER-3 KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER-3. The MFDS reviews the DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER-3 KDMF as part of the drug registration process and uses the information provided in the DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER-3 KDMF to evaluate the safety and efficacy of the drug.
After submitting a DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER-3 KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER-3 API can apply through the Korea Drug Master File (KDMF).
click here to find a list of DIANEAL LOW CALCIUM W/ DEXTROSE 2.5% IN PLASTIC CONTAINER-3 suppliers with KDMF on PharmaCompass.